Security Snapshot

Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT) Institutional Ownership

CUSIP: 76200L309

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

121

Shares (Excl. Options)

90,516,772

Price

$2.36

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
RZLT on Nasdaq
Shares outstanding
95,614,034
Price per share
$3.64
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
90,516,772
Total reported value
$213,617,478
% of total 13F portfolios
0%
Share change
+3,718,177
Value change
-$156,957,499
Number of holders
121
Price from insider filings
$3.64
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • RZLT - Rezolute, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 76200L309.
  • 121 institutions reported positions in Q4 2025.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 121 to 80 between Q4 2025 and Q1 2026.
  • Reported value moved from $213,617,478 to $132,613,114.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 121 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 76200L309?
CUSIP 76200L309 identifies RZLT - Rezolute, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $146,288,898 15,302,186 RA Capital Healthcare Fund, L.P. 11 Dec 2025
Opaleye Management Inc. 6.6% +26% $22,932,000 +$5,049,044 6,300,000 +28% Opaleye Management Inc. 31 Mar 2026
BANK OF AMERICA CORP /DE/ 6.5% $14,372,832 6,064,486 BANK OF AMERICA CORP /DE/ 31 Dec 2025
BALYASNY ASSET MANAGEMENT L.P. 5.3% $18,376,252 5,048,421 Balyasny Asset Management L.P. 31 Mar 2026
BlackRock, Inc. 5.4% $45,886,185 4,881,509 BlackRock, Inc. 30 Sep 2025
Nantahala Capital Management, LLC 4.9% -41% $11,317,609 -$8,350,591 2,857,982 -42% Nantahala Capital Management, LLC 31 Dec 2024
FMR LLC 2.5% -83% $5,379,582 -$24,514,368 2,305,568 -82% FMR LLC 31 Dec 2025

As of 31 Dec 2025, 121 institutional investors reported holding 90,516,772 shares of Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT). This represents 95% of the company’s total 95,614,034 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT) together control 86% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FEDERATED HERMES, INC. 17% 16,534,712 +18% 0.07% $39,021,920
RA CAPITAL MANAGEMENT, L.P. 9.6% 9,180,000 0.22% $21,664,800
BlackRock, Inc. 7.1% 6,768,206 +35% 0% $15,972,966
Opaleye Management Inc. 6.6% 6,287,156 +596% 2% $14,837,688
VANGUARD GROUP INC 5% 4,788,511 +8.6% 0% $11,300,886
Balyasny Asset Management L.P. 4.7% 4,506,861 +147% 0.02% $10,636,192
BANK OF AMERICA CORP /DE/ 4.5% 4,325,248 +237% 0% $10,207,585
STATE STREET CORP 4.2% 3,981,708 +90% 0% $9,396,831
UBS Group AG 2.9% 2,816,291 +4.5% 0% $6,646,447
Affinity Asset Advisors, LLC 2.5% 2,351,144 +12% 0.4% $5,548,700
FMR LLC 2.4% 2,305,568 -82% 0% $5,441,140
Integral Health Asset Management, LLC 2.1% 2,000,000 0% 0.24% $4,720,000
GEODE CAPITAL MANAGEMENT, LLC 2% 1,954,733 +5.8% 0% $4,614,157
BARCLAYS PLC 2% 1,911,066 +517% 0% $4,510,115
MILLENNIUM MANAGEMENT LLC 1.8% 1,711,194 +855% 0% $4,038,418
Vestal Point Capital, LP 1.8% 1,686,000 0.15% $3,978,960
MORGAN STANLEY 1.6% 1,516,435 +349% 0% $3,578,786
JANE STREET GROUP, LLC 1.5% 1,407,699 +1182% 0% $3,322,170
GOLDMAN SACHS GROUP INC 1.4% 1,304,782 +141% 0% $3,079,286
AMERIPRISE FINANCIAL INC 1.1% 1,093,925 +335% 0% $2,581,663
GREAT POINT PARTNERS LLC 1% 951,809 -61% 0.73% $2,246,269
22NW, LP 0.86% 820,653 0% 1.5% $1,936,741
Velan Capital Investment Management LP 0.78% 750,000 0% 1% $1,770,000
NORTHERN TRUST CORP 0.77% 737,315 -4.5% 0% $1,740,063
KENNEDY CAPITAL MANAGEMENT LLC 0.73% 697,855 +2292% 0.03% $1,646,938

Institutional Holders of Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 43,482,359 $132,613,114 -$4,724,504 $3.05 80
2025 Q4 90,516,772 $213,617,478 -$156,957,499 $2.36 121
2025 Q3 86,920,142 $817,052,884 +$108,361,490 $9.40 115
2025 Q2 77,913,169 $347,492,575 +$151,537,051 $4.46 91
2025 Q1 45,040,344 $130,615,009 -$811,015 $2.90 76
2024 Q4 43,207,187 $211,713,139 +$30,093,702 $4.90 71
2024 Q3 38,544,894 $186,942,117 -$3,938,820 $4.85 59
2024 Q2 39,525,913 $169,961,526 +$54,178,980 $4.30 51
2024 Q1 27,042,621 $68,962,251 +$246,860 $2.55 33
2023 Q4 28,952,301 $28,740,703 +$4,794,203 $0.99 31
2023 Q3 23,889,501 $31,534,322 -$458,985 $1.32 29
2023 Q2 24,223,878 $47,962,915 +$49,684 $1.98 28
2023 Q1 24,226,408 $46,514,454 -$475,670 $1.92 31
2022 Q4 24,450,852 $50,611,801 -$822,266 $2.07 34
2022 Q3 24,446,950 $67,002,000 -$497,915 $2.74 30
2022 Q2 24,538,369 $79,207,000 +$56,346,030 $3.23 33
2022 Q1 7,085,710 $23,951,000 -$2,289,045 $3.38 19
2021 Q4 7,529,707 $35,989,000 +$22,778,341 $4.78 21
2021 Q3 2,373,215 $17,647,000 +$1,206,770 $7.48 13
2021 Q2 2,211,492 $31,558,000 -$1,377,636 $14.27 11
2021 Q1 2,477,026 $17,487,000 -$208,256 $7.06 10
2020 Q4 2,506,346 $30,230,000 +$30,230,000 $11.99 7
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .